Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 13.00
+0.10 (0.78%)
At close: Mar 9, 2026
Advent Pharma Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.45 | 1.77 | 3.97 | 1.07 | 4.31 | 2.69 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 40 | Upgrade
|
| Cash & Short-Term Investments | 3.45 | 1.77 | 3.97 | 1.07 | 4.31 | 42.69 | Upgrade
|
| Cash Growth | -6.18% | -55.41% | 269.51% | -75.11% | -89.89% | -7.88% | Upgrade
|
| Receivables | 236.92 | 188.52 | 142.81 | 126.49 | 116.17 | 114.02 | Upgrade
|
| Inventory | 67.32 | 66.17 | 67.24 | 79.75 | 81.33 | 75.41 | Upgrade
|
| Prepaid Expenses | - | - | 0.05 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Other Current Assets | 28.18 | 28.15 | 28.01 | 29.83 | 32.72 | 29.81 | Upgrade
|
| Total Current Assets | 335.86 | 284.61 | 242.08 | 237.2 | 234.59 | 261.98 | Upgrade
|
| Property, Plant & Equipment | 1,630 | 1,648 | 1,615 | 1,551 | 1,409 | 1,258 | Upgrade
|
| Total Assets | 1,965 | 1,932 | 1,857 | 1,788 | 1,644 | 1,520 | Upgrade
|
| Accounts Payable | 10.04 | 10.08 | 9.64 | 20.6 | 10.42 | 8.92 | Upgrade
|
| Accrued Expenses | 52.6 | 47.49 | 43.87 | 61.51 | 48.74 | 38.96 | Upgrade
|
| Short-Term Debt | 58.67 | 58.67 | 60 | 54.99 | 43.27 | 36.83 | Upgrade
|
| Current Portion of Long-Term Debt | 7.91 | 7.91 | 7.91 | 7.91 | 7.91 | 7.91 | Upgrade
|
| Current Portion of Leases | - | 0.7 | 0.67 | 0.76 | 0.64 | 0.61 | Upgrade
|
| Current Income Taxes Payable | 61.59 | 60.12 | 54.69 | 53.3 | 55.6 | 52.41 | Upgrade
|
| Other Current Liabilities | 6.77 | 3.9 | 12.1 | 7.24 | 2.99 | 6.67 | Upgrade
|
| Total Current Liabilities | 197.59 | 188.86 | 188.88 | 206.32 | 169.57 | 152.31 | Upgrade
|
| Long-Term Debt | 7.43 | 7.43 | 7.43 | 7.43 | 11.02 | 14.56 | Upgrade
|
| Long-Term Leases | 1.78 | 1.08 | - | 0.49 | 1.08 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 209.36 | 204.4 | 190.41 | 175.2 | 148.56 | 118.99 | Upgrade
|
| Total Liabilities | 416.16 | 401.77 | 386.72 | 389.44 | 330.23 | 285.86 | Upgrade
|
| Common Stock | 931.33 | 931.33 | 931.33 | 931.33 | 931.33 | 913.07 | Upgrade
|
| Retained Earnings | 617.96 | 599.04 | 538.68 | 467.73 | 382.12 | 321.11 | Upgrade
|
| Shareholders' Equity | 1,549 | 1,530 | 1,470 | 1,399 | 1,313 | 1,234 | Upgrade
|
| Total Liabilities & Equity | 1,965 | 1,932 | 1,857 | 1,788 | 1,644 | 1,520 | Upgrade
|
| Total Debt | 75.79 | 75.79 | 76.01 | 71.59 | 63.92 | 59.91 | Upgrade
|
| Net Cash (Debt) | -72.35 | -74.03 | -72.04 | -70.52 | -59.61 | -17.22 | Upgrade
|
| Net Cash Per Share | -0.78 | -0.79 | -0.77 | -0.76 | -0.64 | -0.18 | Upgrade
|
| Filing Date Shares Outstanding | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | Upgrade
|
| Total Common Shares Outstanding | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | Upgrade
|
| Working Capital | 138.28 | 95.75 | 53.2 | 30.88 | 65.02 | 109.67 | Upgrade
|
| Book Value Per Share | 16.64 | 16.43 | 15.78 | 15.02 | 14.10 | 13.25 | Upgrade
|
| Tangible Book Value | 1,549 | 1,530 | 1,470 | 1,399 | 1,313 | 1,234 | Upgrade
|
| Tangible Book Value Per Share | 16.64 | 16.43 | 15.78 | 15.02 | 14.10 | 13.25 | Upgrade
|
| Land | - | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
| Buildings | - | 1,245 | 1,245 | 1,245 | 1,123 | 925.16 | Upgrade
|
| Machinery | - | 570.15 | 530.34 | 527.92 | 458.43 | 442.57 | Upgrade
|
| Construction In Progress | - | 178.95 | 124.58 | 15.86 | 7.39 | 29.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.